We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNOW icon
401
Snowflake
SNOW
$98.1B
$3.9M 0.02%
11,523
-5,583
-33% -$1.95M
DYN icon
402
Dyne Therapeutics
DYN
$4.15B
$3.85M 0.02%
323,393
– –
SNAP icon
403
Snap
SNAP
$7.96B
$3.83M 0.02%
81,327
+31,240
+62% +$1.76M
STT icon
404
State Street
STT
$48.4B
$3.81M 0.02%
41,001
-2,543
-6% -$240K
RNAM
405
DELISTED
Avidity Biosciences
RNAM
$3.8M 0.02%
159,988
+1,400
+0.9% +$33.4K
COO icon
406
Cooper Companies
COO
$14.2B
$3.8M 0.02%
36,284
-27,908
-43% -$2.84M
BAX icon
407
Baxter International
BAX
$12.8B
$3.8M 0.02%
44,245
-4,657
-10% -$375K
IFF icon
408
International Flavors & Fragrances
IFF
$20.3B
$3.78M 0.02%
25,101
+769
+3% +$112K
TRU icon
409
TransUnion
TRU
$16B
$3.77M 0.02%
31,821
+1,946
+7% +$223K
RJF icon
410
Raymond James Financial
RJF
$33.5B
$3.77M 0.02%
37,530
-826
-2% -$81.6K
KMB icon
411
Kimberly-Clark
KMB
$37.6B
$3.75M 0.02%
26,268
-5,383
-17% -$725K
SPG icon
412
Simon Property Group
SPG
$76.4B
$3.75M 0.02%
18,663
-1,399
-7% -$214K
AMP icon
413
Ameriprise Financial
AMP
$47.8B
$3.74M 0.02%
12,388
-1,318
-10% -$390K
AKAM icon
414
Akamai
AKAM
$15.6B
$3.73M 0.02%
31,854
+8,152
+34% +$897K
MRVL icon
415
Marvell Technology
MRVL
$147B
$3.68M 0.02%
42,039
-3,972
-9% -$297K
PGR icon
416
Progressive
PGR
$128B
$3.66M 0.02%
35,650
+737
+2% +$70.3K
TDOC icon
417
Teladoc Health
TDOC
$1.66B
$3.63M 0.02%
39,545
-2,585
-6% -$309K
TMUS icon
418
T-Mobile US
TMUS
$195B
$3.63M 0.02%
31,299
-1,025
-3% -$121K
VTRS icon
419
Viatris
VTRS
$20.8B
$3.62M 0.02%
267,552
-4,685
-2% -$62.6K
EBAY icon
420
eBay
EBAY
$51.2B
$3.62M 0.02%
54,375
-1,875
-3% -$134K
BLDP
421
Ballard Power Systems
BLDP
$754M
$3.6M 0.02%
286,783
-39,722
-12% -$601K
ESS icon
422
Essex Property Trust
ESS
$19.1B
$3.6M 0.02%
10,228
+5,386
+111% +$1.83M
FDX icon
423
FedEx
FDX
$73B
$3.59M 0.02%
13,871
-1,998
-13% -$480K
AXSM icon
424
Axsome Therapeutics
AXSM
$11.7B
$3.56M 0.02%
94,357
-59,245
-39% -$2.18M
IT icon
425
Gartner
IT
$11.1B
$3.56M 0.02%
10,657
-412
-4% -$132K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.